Early or late administration of Nirmatrelvir/ritonavir in mild COVID-19 patients with clinical comorbidities: A propensity score-matched territory-wide study
Early or late administration of Nirmatrelvir/ritonavir in mild COVID-19 patients with clinical comorbidities: A propensity score-matched territory-wide study
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started